ストックスクリーナーアプリを入手
2.31
1.70%
-0.04
プレマーケット:
2.27
-0.04
-1.73%
前日終値:
$2.35
開ける：
$2.35
24時間の取引高:
579.52K
Relative Volume:
0.54
時価総額：
$153.67M
収益：
$488.00K
当期純損益:
$-41.44M
株価収益率:
-2.4839
EPS:
-0.93
ネットキャッシュフロー:
$-31.47M
1週間 パフォーマンス:
+0.87%
1か月 パフォーマンス:
+5.48%
6か月 パフォーマンス:
-18.09%
1年 パフォーマンス:
-27.93%
1日の値動き範囲:
$2.25
$2.35
1週間の範囲:
$2.20
$2.38
52週間の値動き範囲:
$1.90
$5.6395
Cardiff Oncology Inc Stock (CRDF) Company Profile
名前
Cardiff Oncology Inc
セクター
電話
858-952-7570
住所
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
CRDF を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRDF
Cardiff Oncology Inc
|
2.31 | 156.34M | 488.00K | -41.44M | -31.47M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-08 | 開始されました | Ladenburg Thalmann | Buy |
| 2025-06-24 | 開始されました | Jefferies | Hold |
| 2024-09-06 | 開始されました | Craig Hallum | Buy |
| 2022-01-05 | 開始されました | William Blair | Outperform |
| 2021-12-08 | 開始されました | Robert W. Baird | Outperform |
| 2021-08-09 | 再開されました | Maxim Group | Buy |
| 2020-10-22 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-08 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Cardiff Oncology Inc (CRDF) 最新ニュース
Is Cardiff Oncology Inc. reversing from oversold territoryRisk Management & Risk Managed Trade Strategies - newser.com
Can Cardiff Oncology Inc. (XE7C) stock stage a strong rebound this quarterLong Setup & Real-Time Stock Entry Alerts - newser.com
Will Cardiff Oncology Inc. stock gain from strong economyWeekly Market Report & Daily Chart Pattern Signals - newser.com
What technical signals suggest for Cardiff Oncology Inc. stockSwing Trade & Long-Term Safe Investment Ideas - newser.com
Can Cardiff Oncology Inc. (XE7C) stock sustain breakout momentum2025 Performance Recap & Risk Managed Trade Strategies - newser.com
Tools to monitor Cardiff Oncology Inc. recovery probabilityFed Meeting & Accurate Entry/Exit Alerts - newser.com
Is Cardiff Oncology Inc. stock a safe investment in uncertain marketsTake Profit & Daily Profit Focused Stock Screening - newser.com
What is the fair value of Cardiff Oncology Inc. stock nowMarket Volume Summary & AI Based Buy and Sell Signals - newser.com
Combining price and volume data for Cardiff Oncology Inc.Earnings Risk Report & Advanced Technical Signal Analysis - newser.com
How Cardiff Oncology Inc. (XE7C) stock reacts to stronger dollar2025 Fundamental Recap & AI Driven Stock Reports - newser.com
Can Cardiff Oncology Inc. hit a new high this monthDip Buying & Advanced Swing Trade Entry Alerts - newser.com
Will Cardiff Oncology Inc. stock gain from lower inflationLong Setup & Expert Approved Momentum Trade Ideas - newser.com
How Cardiff Oncology Inc. stock reacts to Fed rate cutsTrade Volume Report & AI Driven Stock Reports - newser.com
Should you hold or exit Cardiff Oncology Inc. now2025 EndofYear Setup & Trade Opportunity Analysis - newser.com
What dividend safety score for Cardiff Oncology Inc. stock2025 Institutional Moves & Weekly Watchlist for Consistent Profits - newser.com
How to interpret RSI for Cardiff Oncology Inc. stockJuly 2025 Closing Moves & Daily Momentum Trading Reports - newser.com
How Cardiff Oncology Inc. stock trades during market volatility2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Cardiff Oncology Inc XE7C Stock Analysis and ForecastSector ETF Performance & Accelerated Financial Growth - earlytimes.in
What hedge fund activity signals for Cardiff Oncology Inc. stock2025 Price Targets & Expert Curated Trade Setup Alerts - newser.com
Can Cardiff Oncology Inc. (XE7C) stock double in coming yearsPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Cardiff Oncology Inc (CRDF) 財務データ
収益
当期純利益
現金流量
EPS
0.64%
0.35%
大文字化:
|
ボリューム (24 時間):